https://www.avient.com/sites/default/files/resources/FAQs%2520for%2520PolyOne%2520GHS%2520Requirements%2520Ver%252006%2520April%25202015.pdf
Some changes will come later than others since we will be phasing in some changes such as new
hazard pictograms on both the SDS and the labels to more closely match the timeline required in the U.S.
As a result of more information being required than before, we can expect the
SDSs to become longer than the original MSDSs for the same products.
Click Here to learn more about GHS labeling guidelines in the United
States.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Bio-based Polymer Solutions Application Bulletin.pdf
Mevopur™ Healthcare Bio-based Polymer Solutions
for Medical Devices and Pharmaceutical Packaging
Manufacturers of medical devices and
pharmaceutical packaging are increasingly faced
with the challenge of integrating sustainability into
the design of their products.
Processing conditions can cause material properties to shift from the values stated in the information.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.
https://www.avient.com/sites/default/files/2023-03/Mevopur Healthcare Functional Additives Nucleating Application Bulletin.pdf
Processing conditions can cause material properties to shift from the values stated in the information.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative.
1.844.4AVIENT
www.avient.com
https://www.avient.com/resources/safety-data-sheets?page=5720
MD-34587 RED TRIDENT
MD-34634 DARK RED
Learn More
https://www.avient.com/sites/default/files/2024-11/Dispersions Healthcare Industry Bulletin.pdf
Medical devices and equipment are at
the forefront of this change, with innovations in
diagnostic tools, surgical systems, and wearable
health monitors reshaping patient care.
Processing conditions can cause material properties to shift from the values stated in the information.
Ready to learn more?
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Colorants and Formulations Special Effects Application Bulletin_0.pdf
Mevopur™ Healthcare Colorants and Formulations
Special Effect Colorants for Healthcare Devices and
Pharmaceutical Packaging
Self-administered medication, for example via
pen devices and inhalers, has been the norm for
many years.
Designers are looking for ways to make their
devices easier to use and more attractive—special
effects can help this.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.
https://www.avient.com/sites/default/files/2023-01/Mevopur Standard Colors Product Bulletin _ Color Card.pdf
With
robust raw material testing and a comprehensive
change control policy, these medical-grade
concentrates and pre-colored formulations can
help minimize risk and avoid non-compliance.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative.
1.844.4AVIENT
www.avient.com
https://www.avient.com/knowledge-base/case-study/material-cuts-delays-contact-lens-container-production
In addition to a lower material cost than silicone, the custom TPE offered cycle time efficiencies, lower part weight due to its lower specific gravity, and reduced scrap rates.
Armed with a new specialty TPE solution, the medical manufacturer handled gasket adhesion with a material that outperformed that not only silicone, but also conventional TPEs.
Learn More
https://www.avient.com/knowledge-base/case-study/material-cuts-delays-contact-lens-container-production?rtype[]=1124
In addition to a lower material cost than silicone, the custom TPE offered cycle time efficiencies, lower part weight due to its lower specific gravity, and reduced scrap rates.
Armed with a new specialty TPE solution, the medical manufacturer handled gasket adhesion with a material that outperformed that not only silicone, but also conventional TPEs.
Learn More
https://www.avient.com/knowledge-base/case-study/material-cuts-delays-contact-lens-container-production?ind[]=6598
In addition to a lower material cost than silicone, the custom TPE offered cycle time efficiencies, lower part weight due to its lower specific gravity, and reduced scrap rates.
Armed with a new specialty TPE solution, the medical manufacturer handled gasket adhesion with a material that outperformed that not only silicone, but also conventional TPEs.
Learn More